The 5-Year Outlook for This Dow Stock: Pfizer

By John Reeves | More Articles
February 17, 2012 | Comments (1)

The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor Dave Meier discuss topics across the investing world.

Dave and John consider the prospects of Pfizer over the next five years. They both find its dividend pretty attractive, but they also wonder about its long-term potential. The video concludes with Dave's call on the stock.

If you like Pfizer's yield but are also interested in other dividend-paying companies, The Motley Fool has compiled a special free report outlining our 11 top, dependable, dividend-paying stocks. It's called "Secure Your Future With 11 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Dave Meier and John Reeves have no positions in the stocks mentioned above. The Motley Fool owns shares of Teva Pharmaceutical Industries. Motley Fool newsletter services recommend Pfizer and Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Report this Comment On February 18, 2012, at 12:53 PM, mhtim wrote:

Dave Meier lost credibility with me when he opened with "Pfizer created Lipitor." WARNER-LAMBERT, a company Pfizer aquired, created LIptor!!!

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1783022, ~/Articles/ArticleHandler.aspx, 5/27/2012 6:23:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
	DOW	12,454.83	-74.92	-0.60%
	S&P 500	1,317.82	-2.86	-0.22%
	NASD	2,837.53	-1.85	-0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes